Cencora, Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related servic…
What to know about COR
Cencora, Inc. is a large Healthcare company with a mixed financial profile. It scores well on risk and sentiment, but cash flow is worth keeping an eye on.
Should you consider COR?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Cencora, Inc. is a large-cap Healthcare company with a mixed overall financial profile — it ranks near the bottom of Healthcare stocks (47 of 59).
-
Profit margins are thin compared to most S&P 500 peers — the company keeps less of each dollar it earns than the average. Watch for signs of margin improvement.
-
Valuation looks attractive — the stock is priced reasonably relative to its earnings and sales compared to most peers. You're not overpaying for the business.
-
The company is growing at a reasonable pace — not the fastest, but consistently moving in the right direction.
-
There is a small dividend (0.01%), but income-focused investors will likely find better yields elsewhere in the market.
-
Risk is relatively low — the stock tends to be less volatile than the broader market, which typically means a smoother ride during uncertain periods.
-
Analyst sentiment is broadly positive and short interest is low — professionals who cover this stock are mostly optimistic about its near-term prospects.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how COR compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 20.81 | Above avg |
| Forward P/E | 13.74 | Above avg |
| PEG Ratio | 0.60 | Top 25% |
| Price to Sales | 0.16 | Top 25% |
| Price to Book | 15.57 | Below avg |
| EV/EBITDA | 12.80 | Above avg |
| Earnings Yield | 4.80% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 3.80% | Below avg |
| Operating Margin | 1.72% | Below avg |
| Net Profit Margin | 0.78% | Below avg |
| Return on Equity | 107.13% | Top 25% |
| Return on Invested Capital | 3.49% | Average |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 3.80% | Below avg |
| Revenue Growth (3Y CAGR) | 10.43% | Top 25% |
| EPS Growth (YoY) | 128.30% | Top 25% |
| Free Cash Flow Growth | 6.99% | Above avg |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 0.95 | Average |
| Debt to Equity | 4.21 | Below avg |
| Interest Coverage | 6.38 | Average |
| Altman Z-Score | 4.77 | Above avg |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 0.85% | Below avg |
| Payout Ratio | 17.62% | Above avg |
| Dividend Growth (5Y) | -29.36% | Below avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 2.95% | Average |
| OCF to Sales | 0.69% | Below avg |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.59 | Top 25% |
| Volatility (30-Day) | 22.88% | Top 25% |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 3.22% | Above avg |
| Avg. Analyst Rating | 1.57 | Top 25% |
| Target Upside % | 28.97% | Top 25% |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 52.89B | Above avg |
How does COR compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to COR — based on their financial profile.